Gain Therapeutics Inc
Gain Therapeutics Inc (GANX) Option Chain
As of September 22, 2026, Gain Therapeutics Inc is trading at $1.84, a -5.65% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 160.9%. IV Rank is 17%.
Read more
Tracking the GANX option chain helps you see every strike and expiry on Gain Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Gain Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GANX options activity at a glance. Use our scanner to monitor the GANX option chain in real time and filter for the GANX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GANX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GANX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GANX stock options are being actively traded and where they are not.
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases.
The company was founded in 2017 and is based in Bethesda, Maryland.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Gain Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen GANX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GANX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile50.00% Neutral
- Market cap (M$)80
- 52 weeks high-57.60%
- 52 weeks low20.26%
- Analyst recommendationStrong Buy
1.00 - Target price$7.20
291.30% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-0.51
- EPS growth next 5 years-3.43%
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 3.59 | 1,552 | 113 | 0.46 | 0.84 | 0.80 | 1.80 | 1.00 | -48.72 | — | 1.00 | 0.00 | 1.00 | 0 | 0 | 96.41 |
| 59.37 | 803 | 86 | 0.13 | 0.00 | 0.05 | 0.20 | 2.00 | +2.56 | — | 0.60 | 0.16 | 0.44 | 0 | 521 | 40.63 |
| 92.34 | 142 | 0 | 0.05 | 0.00 | — | 0.05 | 3.00 | +53.85 | 0.65 | 1.65 | 1.16 | -0.01 | 0 | 1 | 7.66 |
| 98.85 | 0 | 0 | 0.20 | 0.00 | — | 0.20 | 4.00 | +105.13 | 1.65 | 2.65 | 2.16 | -0.01 | 0 | 0 | 1.15 |
| 99.83 | 0 | 0 | 1.00 | 0.00 | — | 1.00 | 5.00 | +156.41 | 2.60 | 3.60 | 3.16 | -0.06 | 0 | 0 | 0.17 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full GANX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→